4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-16-091686
Chief Executive Officer sold 2,400 shares at an average $20.20 ($48,468)
From the SEC's structured data for this filing
Trades in this filing
Ciechanover Isaac E. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-01-13 | Sale : show line 1 in the form | −1,200 | $20.32 | $24,384 | 380,411 | I |
| 2016-01-14 | Sale : show line 2 in the form | −1,200 | $20.07 | $24,084 | 379,211 | I |
| Open-market sales · 2,400 sh · avg $20.20 · $48,468 | ||||||
Loading xslF345X03/doc4.xml…